Terri Gaskell

Terri Gaskell

Company: Rinri Therapeutics

Job title: Chief Technology Officer


Accounting for Method & Definition Variation in Potency Assays Caused by Different Engineering Approaches to Enhance Assay Development 2:30 pm

By addressing the impact of different engineering approaches on potency assays, and discussing best practices for improving assay accuracy and reproducibility, this workshop can help ensure cell-based therapies are developed and tested to the highest standards of safety and efficacy. Attend this workshop to: Explore the impact of different engineering approaches on potency assays and…Read more

day: Pre-Conference Workshop Day

Gaining Control of your Manufacturing Process with Clear CQAs, Controlling Advantageous Agents in Biologics 9:30 am

Understanding the principles of critical quality attributes and their role in controlling the manufacturing process of biologics Exploring the challenges and best practices in identifying and controlling advantageous agents in biologics Discussing case studies and success stories of applying CQA and advantageous agent control in cell therapy manufacturing processesRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.